The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-Amino-N-(1-((5,5'-diallyl-2-hydroxy-2'-isopropoxy-[1,1'-biphenyl]-3-yl)methyl)piperidin-4-yl)-3-hydroxypropanamide ID: ALA4756908
PubChem CID: 162657371
Max Phase: Preclinical
Molecular Formula: C30H41N3O4
Molecular Weight: 507.68
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CCc1ccc(OC(C)C)c(-c2cc(CC=C)cc(CN3CCC(NC(=O)[C@@H](N)CO)CC3)c2O)c1
Standard InChI: InChI=1S/C30H41N3O4/c1-5-7-21-9-10-28(37-20(3)4)25(16-21)26-17-22(8-6-2)15-23(29(26)35)18-33-13-11-24(12-14-33)32-30(36)27(31)19-34/h5-6,9-10,15-17,20,24,27,34-35H,1-2,7-8,11-14,18-19,31H2,3-4H3,(H,32,36)/t27-/m0/s1
Standard InChI Key: VUDMFWHPLMHYOV-MHZLTWQESA-N
Molfile:
RDKit 2D
37 39 0 0 0 0 0 0 0 0999 V2000
31.2108 -5.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2096 -6.6897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9244 -7.1027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6408 -6.6892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6380 -5.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9226 -5.4496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3524 -7.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3523 -7.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0666 -8.3373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7814 -7.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7774 -7.0944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0626 -6.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3521 -5.4413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.6372 -8.3374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4948 -7.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7807 -6.6886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0659 -7.1005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4898 -6.6782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2063 -7.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9187 -6.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9201 -4.6246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2044 -4.2142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2046 -3.3858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4930 -2.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7773 -3.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7778 -4.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4940 -4.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0615 -2.9734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6359 -9.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9208 -9.5738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3470 -3.3859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6326 -2.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3471 -4.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6325 -2.1485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9181 -3.3860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2036 -2.9736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3497 -9.5760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
8 14 1 0
2 15 1 0
15 16 1 0
16 17 2 0
11 18 1 0
18 19 1 0
19 20 2 0
6 21 1 0
21 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
14 29 1 0
29 30 1 0
28 31 1 0
31 32 1 0
31 33 2 0
32 34 1 6
32 35 1 0
35 36 1 0
29 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 507.68Molecular Weight (Monoisotopic): 507.3097AlogP: 3.70#Rotatable Bonds: 12Polar Surface Area: 108.05Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.51CX Basic pKa: 9.48CX LogP: 2.51CX LogD: 1.57Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -0.03
References 1. Zhao M,Zheng YH,Zhao QY,Zheng W,Yang JH,Pei HY,Liu L,Liu KJ,Xue LL,Deng DX,Wang L,Ma X,Fu SH,Peng AH,Tang MH,Luo YZ,Ye HY,Chen LJ. (2021) Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy., 209 [PMID:33069436 ] [10.1016/j.ejmech.2020.112922 ]